NEOSTIGMINE METHYLSULFATE and WHITE BLOOD CELL COUNT INCREASED

Overview

WHITE BLOOD CELL COUNT INCREASED is the #8 most commonly reported adverse reaction for NEOSTIGMINE METHYLSULFATE, manufactured by Exela Pharma Sciences, LLC. There are 18 FDA adverse event reports linking NEOSTIGMINE METHYLSULFATE to WHITE BLOOD CELL COUNT INCREASED. This represents approximately 1.9% of all 959 adverse event reports for this drug.

Patients taking NEOSTIGMINE METHYLSULFATE who experience white blood cell count increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

WHITE BLOOD CELL COUNT INCREASED is a less commonly reported adverse event for NEOSTIGMINE METHYLSULFATE, but still significant enough to appear in the safety profile.

Other Side Effects of NEOSTIGMINE METHYLSULFATE

In addition to white blood cell count increased, the following adverse reactions have been reported for NEOSTIGMINE METHYLSULFATE:

• DRUG INEFFECTIVE — 53 reports
• ABDOMINAL DISTENSION — 26 reports
• HYPOTENSION — 26 reports
• NAUSEA — 23 reports
• CARDIAC ARREST — 21 reports
• ABDOMINAL PAIN — 20 reports
• RESPIRATORY FAILURE — 20 reports
• PYREXIA — 16 reports
• BRADYCARDIA — 15 reports
• GENERALISED TONIC CLONIC SEIZURE — 15 reports

Other Drugs Associated with WHITE BLOOD CELL COUNT INCREASED

The following drugs have also been linked to white blood cell count increased in FDA adverse event reports:

Does NEOSTIGMINE METHYLSULFATE cause WHITE BLOOD CELL COUNT INCREASED?

WHITE BLOOD CELL COUNT INCREASED has been reported as an adverse event in 18 FDA reports for NEOSTIGMINE METHYLSULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is WHITE BLOOD CELL COUNT INCREASED with NEOSTIGMINE METHYLSULFATE?

WHITE BLOOD CELL COUNT INCREASED accounts for approximately 1.9% of all adverse event reports for NEOSTIGMINE METHYLSULFATE, making it a notable side effect.

What should I do if I experience WHITE BLOOD CELL COUNT INCREASED while taking NEOSTIGMINE METHYLSULFATE?

If you experience white blood cell count increased while taking NEOSTIGMINE METHYLSULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages